Sale by Jane Henderson (Chief Financial Officer)
2,000 shares · @ $82.04 · $164,080
Apogee Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $79.30
+1.5% in 1d after detection
Post-detection moves
1h
—
1d
+1.5%
3d
-0.3%
7d
+0.7%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS